Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

NCT01003405 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: KUC-7483

Sponsor

Kissei Pharmaceutical Co., Ltd.